Form 4: Pacific Biosciences CEO Christian Henry Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Christian Henry sold 14,177 shares of Pacific Biosciences stock on March 4, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 4, 2024, Christian Henry, the President & CEO of Pacific Biosciences, sold 14,177 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $4.871, with individual prices ranging from $4.72 to $5.22 per share.
- Following the transaction, Henry directly owns 2,596,670 shares of Pacific Biosciences stock.
Sentiment
Score: 5
Explanation: This is a neutral event. The sale is related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.
Industry Context
This is a routine transaction for executives who receive stock as part of their compensation. It is common for them to sell a portion of their shares to cover the taxes due when the stock vests.
Key Dates
| Date | Description |
|---|---|
| 03/04/2024 | Date of the stock sale transaction. |
| 03/06/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.